Photobiomodulation and Parkinson
Parkinson Disease
About this trial
This is an interventional treatment trial for Parkinson Disease focused on measuring movement disorders, light therapy, motor aspects
Eligibility Criteria
Inclusion Criteria:
- Having been diagnosed with idiopathic PD.
- Stage 1-2 on the Hoehn and Yahr Scale.
- Having no neurological condition other than PD.
- Being able to stand for 2 minutes and walk 10 meters without assistance.
- Having no severe dyskinesias or "ON-OFF" phases.
Exclusion Criteria:
- Do not follow inclusion criteria.
Sites / Locations
- University School of Sports Medicine, University of Oviedo, Spain.
- Department of Physical Education and Sport, University of León
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Photobiomodulation group
Sham group
17 Parkinson´s disease patients were randomly assigned to the photobiomodulation group (experimental group). Intervention: Photobiomodulation was administered using red light-emitting diodes (LEDs) with a 670-nm wavelength in six 1-minute blocks alternating the LEDs between the right and left temples, with a 30-second rest between blocks.
18 Parkinson´s disease patients were randomly assigned to the sham group. Intervention: Procedures for the sham group were identical as the photobiomodulation one, except that patients received photobiomodulation during only 5 seconds followed by 55 seconds with no treatment (equalling 1/12th of the energy used for the intervention group).